Login to Your Account



XOMA, Dyax Cross-Licensing Antibody, Phage Display Rights

By Randall Osborne


Thursday, October 17, 2002
XOMA Ltd. entered its third antibody licensing deal of the year, this one an arrangement with Dyax Corp., which is providing not only payments but also access to its antibody library and a license to its important Ladner phage display patents. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription